4//SEC Filing
ROTE WILLIAM E. 4
Accession 0001209191-23-029000
CIK 0001438533other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:09 PM ET
Size
5.2 KB
Accession
0001209191-23-029000
Insider Transaction Report
Form 4
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Transactions
- Sale
Common Stock
2023-05-10$16.59/sh−825$13,687→ 59,211 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were made pursuant to a written plan adopted by the Reporting Person on November 10, 2022 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001698262
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:09 PM ET
- Size
- 5.2 KB